Success Metrics

Clinical Success Rate
88.9%

Based on 32 completed trials

Completion Rate
89%(32/36)
Active Trials
11(16%)
Results Posted
31%(10 trials)
Terminated
4(6%)

Phase Distribution

Ph phase_3
8
12%
Ph phase_1
4
6%
Ph phase_2
6
9%
Ph early_phase_1
2
3%
Ph not_applicable
48
71%

Phase Distribution

6

Early Stage

6

Mid Stage

8

Late Stage

Phase Distribution68 total trials
Early Phase 1First-in-human
2(2.9%)
Phase 1Safety & dosage
4(5.9%)
Phase 2Efficacy & side effects
6(8.8%)
Phase 3Large-scale testing
8(11.8%)
N/ANon-phased studies
48(70.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

86.5%

32 of 37 finished

Non-Completion Rate

13.5%

5 ended early

Currently Active

11

trials recruiting

Total Trials

68

all time

Status Distribution
Active(17)
Completed(32)
Terminated(5)
Other(14)

Detailed Status

Completed32
unknown14
Recruiting10
Not yet recruiting6
Terminated4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
68
Active
11
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (2.9%)
Phase 14 (5.9%)
Phase 26 (8.8%)
Phase 38 (11.8%)
N/A48 (70.6%)

Trials by Status

unknown1421%
withdrawn11%
active_not_recruiting11%
completed3247%
not_yet_recruiting69%
recruiting1015%
terminated46%

Recent Activity

Clinical Trials (68)

Showing 20 of 68 trialsScroll for more
NCT07361653Not Applicable

The REVIVE Pivotal Study

Not Yet Recruiting
NCT07482696Not Applicable

Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation

Not Yet Recruiting
NCT05521854Not Applicable

Contingency Management for Drug Use: Does Age Matter?

Active Not Recruiting
NCT04592445Not Applicable

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

Recruiting
NCT07468383Not Applicable

Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia

Recruiting
NCT04927143Not Applicable

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

Recruiting
NCT07403760Not Applicable

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly

Recruiting
NCT07403058Not Applicable

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction

Not Yet Recruiting
NCT03042988Not Applicable

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Recruiting
NCT05089656Phase 3

Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)

Completed
NCT05465070Not Applicable

Leg Heat Therapy in Peripheral Artery Disease

Recruiting
NCT07192757Not Applicable

Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss

Recruiting
NCT07268001Not Applicable

Effects of Continuous Theta Burst Stimulation on Emotional Attention

Completed
NCT06928116Not Applicable

Heat thErapy And mobiLity in COVID-19 Survivors

Recruiting
NCT07196592Not Applicable

Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI

Not Yet Recruiting
NCT07165899Not Applicable

Effects of Exposure to a Single-electrode Electroencephalography-guided Binaural Beat Audio Track on Sustained Attention and Subjective Well-being Among Healthy Adults

Completed
NCT05277389Early Phase 1

New Tool to Enhance Post-stroke Upper Extremity Disability

Completed
NCT05679063Not Applicable

Therapeutic Exercise and Education in Neurophysiology of Pain in the Quality of Life of Women With Endometriosis

Completed
NCT06990165Not Applicable

Photobiomodulation in Radiodermatitis in People With Breast Cancer

Not Yet Recruiting
NCT03503773Phase 2

The TARGET BP OFF-MED Trial

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
68